AstraZeneca announces 'robust' results from anti-COVID drug trial
Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.
Nov 18, 2021
0
56